SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008053
Filing Date
2024-05-14
Accepted
2024-05-14 07:00:36
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q epix-20240331x10q.htm   iXBRL 10-Q 1478769
2 EX-31.1 epix-20240331xex31d1.htm EX-31.1 7127
3 EX-31.2 epix-20240331xex31d2.htm EX-31.2 7117
4 EX-32.1 epix-20240331xex32d1.htm EX-32.1 9203
5 GRAPHIC epix-20240331x10q001.jpg GRAPHIC 17235
6 GRAPHIC epix-20240331x10q003.jpg GRAPHIC 38174
7 GRAPHIC epix-20240331x10q004.jpg GRAPHIC 38064
  Complete submission text file 0001558370-24-008053.txt   5609653

Data Files

Seq Description Document Type Size
8 EX-101.SCH epix-20240331.xsd EX-101.SCH 36121
9 EX-101.CAL epix-20240331_cal.xml EX-101.CAL 36512
10 EX-101.DEF epix-20240331_def.xml EX-101.DEF 107319
11 EX-101.LAB epix-20240331_lab.xml EX-101.LAB 292493
12 EX-101.PRE epix-20240331_pre.xml EX-101.PRE 214077
66 EXTRACTED XBRL INSTANCE DOCUMENT epix-20240331x10q_htm.xml XML 878356
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 24941414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)